Rianne Biemans on Muck Rack

Rianne Biemans

As seen in: Nature, Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rianne

Contact Rianne, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Predicting homologous recombination deficiency and treatment responses using a computed tomography-based foundation model: a preclinical study - npj Precision Oncology

|
By Min Wu, Zohaib Salahuddin, Natasja G. Lieuwes, Rianne Biemans, Jennifer Jung, Ala Yaromina, Ludwig J. Dubois, Henry Woodruff, Philippe Lambin, Sheng Kuang, Lesley Schuitmaker
| Nature Verified
Abstract Homologous recombination deficiency (HRD) can lead to genomic instability, increased cancer susceptibility, and enhanced sensitivity to DNA-targeting therapies. Although radiomics has been used for various medical applications, its application in animal studies remains largely unexplored, primarily due to the typically limited availability of preclinical data.
Open in Who Shared Issue with article?

Targeting glucose and glutamine metabolism combined with radiation therapy in non-small cell lung cancer

|
By Ludwig J. Dubois, Rianne Biemans, Tineke W. H. Meijer, Wenny J. M. Peeters
| Lung Cancer Verified
Publication HistoryPublished online: October 15, 2018Accepted: October 13, 2018; Received in revised form: September 18, 2018; Received: March 23, 2018;
Open in Who Shared Issue with article?

Distinct radiation responses after in vitro mtDNA depletion are potentially related to oxidative stress

|
By Rianne Biemans, Roland F. Hoffmann, Marie-José Drittij-Reijnders, Irene H. Heijink
| PLOS
Several clinically used drugs are mitotoxic causing mitochondrial DNA (mtDNA) variations, and thereby influence cancer treatment response. We hypothesized that radiation responsiveness will be enhanced in cellular models with decreased mtDNA content, attributed to altered reactive oxygen species (ROS) production and antioxidant capacity. For this purpose BEAS-2B, A549, and 143B cell lines were depleted from their mtDNA (?0).
Open in Who Shared Issue with article?
See all 4 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified